ACI患者治疗前后血浆ET-1和血清NSE、NPY联检的临床意义

摘要

目的:评估了急性脑梗死(ACI)患者治疗前后血浆内皮素-1(ET-1)和血清神经元特异性烯醇化酶(NSE)、神经肽-Y(NPY)水平的变化及临床意义.方法:应用放射免疫分析对32例ACI患者进行了治疗前后血浆ET-1和血清NSE、NPY检测,并与35名正常健康人作比较.结果:在治疗前血浆ET-1和血清NSE、NPY水平均非常显著地高于正常人组(P＜0.01),经治疗3个月后与正常人组比较仍有显著性差异(P＜0.05).结论:测定ACI患者治疗前后血浆ET-1和血清NSE、NPY水平对观察病情和预后判定具有重要的临床价值.%Objective To explore the changes of plasma ET-1 and serum NSE, NPY levels both before and after treatment in patients with acute cerebral infarction and their significance. Methods Plasma ET-1 and serum NSE, NPY levels were measured with RIA in 32 patients with acute cerebral infarction both before and after treatment as well as in 35 controls. Results Before treatment plasma ET-1 and serum NSE, NPY levels were significantly higher than those in contrrols ( P ＜ 0.01 ). After for 3 months of treatment,the levels dropped markedly, but still remained significant higher ( P ＜ 0.05 ). Conclusion Changes of plasma ET-1 and serum NSE, NPY contents both before and after treatment might be of prognostic importance in patients with acute cerebral infarction.